SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients

Author:

Brito-Zerón Pilar12,Melchor Sheila3ORCID,Seror Raphaèle4,Priori Roberta5,Solans Roser6,Kostov Belchin789,Baldini Chiara10,Carubbi Francesco11,Callejas Jose Luis12,Guisado-Vasco Pablo13,Hernández-Molina Gabriela14,Pasoto Sandra G15,Valim Valeria16,Sisó-Almirall Antoni7817,Mariette Xavier18,Carreira Patricia3,Ramos-Casals Manuel11719,Brito-Zerón P,Morcillo C,Brito-Zerón P,Flores-Chávez A,Ramos-Casals M,Acar-Denizli N,Horvath I F,Szanto A,Tarr T,Seror R,Mariette X,Mandl T,Olsson P,Li X,Xu B,Baldini C,Bombardieri S,Gottenberg J E,Gandolfo S,De Vita S,Priori R,Giardina F,Hernandez-Molina GORCID,Sánchez-Guerrero J,Kruize A A,Hinrichs A,Valim V,Isenberg D,Solans R,Rischmueller M,Downie-Doyle S,Kwok S-K,Park S-H,Nordmark G,Suzuki Y,Kawano M,Giacomelli R,Devauchelle-Pensec V,Saraux A,Hofauer B,Knopf A,Bootsma H,Vissink A,Morel J,Vollenveider C,Atzeni F,Retamozo S,Moça Trevisano V,Armagan B,Kilic L,Kalyoncu U,Pasoto S G,Kostov B,Sisó-Almirall A,Consani-Fernández S,Carubbi F,Callejas J L,López-Dupla M,Pérez-Alvarez R,Akasbi M,Guisado-Vasco P,Sánchez I,

Affiliation:

1. Laboratory of Autoimmune Diseases Josep Font, IDIBAPS-CELLEX, Barcelona, Spain

2. Autoimmune Diseases Unit, Department of Medicine, Hospital CIMA- Sanitas, Barcelona, Spain

3. Servicio de Reumatologia, Hospital Universitario, 12 de Octubre, Madrid, Spain

4. Department of Rheumatology, National Reference Center for Sjögren Syndrome and Rare Autoimmune Diseases, Université Paris-Saclay, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Paris-Sud, AP-HP, Le Kremlin Bicêtre, France

5. Department of Internal Medicine and Medical Specialties, Rheumatology Clinic, Sapienza University of Rome, Rome, Italy

6. Department of Internal Medicine, Hospital Vall d'Hebron, Barcelona, Spain

7. Primary Care Centre Les Corts, Consorci d’Atenció Primària de Salut Barcelona Esquerra (CAPSBE), Barcelona, Spain

8. Primary healthcare transversal research group, Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain

9. Department of Statistics and Operations Research, Universitat Politècnica de Catalunya (UPC), Barcelona, Spain

10. Rheumatology Unit, University of Pisa, Pisa, Italy

11. COVID-19 Medical Unit, San Salvatore Hospital, Department of Medicine, ASL1 Avezzano-Sulmona-L’Aquila, L’Aquila, Italy

12. Department of Internal Medicine, Hospital San Cecilio, Granada, Spain

13. Department of Internal Medicine, Hospital Universitario Quironsalud, Madrid, Spain

14. Immunology and Rheumatology Department, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, México City, Mexico

15. Rheumatology Division, Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, Sao Paulo, Brazil

16. Department of Medicine, Federal University of Espírito Santo, Vitória, Brazil

17. Department of Medicine, Universitat de Barcelona, Barcelona, Spain

18. Centre for Immunology of Viral Infections and Autoimmune Diseases, Assistance Publique – Hôpitaux de Paris, Hôpitaux Universitaires Paris-Saclay, Le Kremlin-Bicêtre, Université Paris-Saclay, INSERM, Paris, France

19. Department of Autoimmune Diseases, ICMiD, Hospital Clínic, Barcelona, Spain

Abstract

Abstract Objective To analyse the prognosis and outcomes of SARS-CoV-2 infection in patients with primary SS. Methods We searched for patients with primary SS presenting with SARS-CoV-2 infection (defined following and according to the European Centre for Disease Prevention and Control guidelines) among those included in the Big Data Sjögren Registry, an international, multicentre registry of patients diagnosed according to the 2002/2016 classification criteria. Results A total of 51 patients were included in the study (46 women, mean age at diagnosis of infection of 60 years). According to the number of patients with primary SS evaluated in the Registry (n = 8211), the estimated frequency of SARS-CoV-2 infection was 0.62% (95% CI 0.44, 0.80). All but two presented with symptoms suggestive of COVID-19, including fever (82%), cough (57%), dyspnoea (39%), fatigue/myalgias (27%) and diarrhoea (24%), and the most frequent abnormalities included raised lactate dehydrogenase (LDH) (88%), CRP (81%) and D-dimer (82%) values, and lymphopenia (70%). Infection was managed at home in 26 (51%) cases and 25 (49%) required hospitalization (five required admission to ICU, four died). Compared with patients managed at home, those requiring hospitalization had higher odds of having lymphopenia as laboratory abnormality (adjusted OR 21.22, 95% CI 2.39, 524.09). Patients with comorbidities had an older age (adjusted OR 1.05, 95% CI 1.00, 1.11) and showed a risk for hospital admission six times higher than those without (adjusted OR 6.01, 95% CI 1.72, 23.51) in the multivariate analysis. Conclusion Baseline comorbidities were a key risk factor for a more complicated COVID-19 in patients with primary SS, with higher rates of hospitalization and poor outcomes in comparison with patients without comorbidities.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3